Molecular Templates, Inc. (MTEM) financial statements (2020 and earlier)

Company profile

Business Address 9301 AMBERGLEN BLVD
AUSTIN, TX 78729
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments125985924495966
Cash and cash equivalents858859111087
Short-term investments4010 13395058
Receivables80     
Prepaid expense221    
Other current assets040    
Other undisclosed current assets5  14820
Total current assets:1401056024536786
Noncurrent Assets
Operating lease, right-of-use asset10
Property, plant and equipment18720011
Long-term investments and receivables2     16
Long-term investments2     16
Other noncurrent assets521 011
Other undisclosed noncurrent assets 2727    
Total noncurrent assets:34353000218
TOTAL ASSETS:17414090245468104
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities16652485
Accounts payable1131122
Accrued liabilities15531333
Employee-related liabilities     3 
Deferred revenue17
Debt 02    
Deferred revenue and credits3  1515
Other liabilities300    
Other undisclosed current liabilities 26 1737
Total current liabilities:3633103112627
Noncurrent Liabilities
Long-term debt and lease obligation1531    
Long-term debt, excluding current maturities331    
Capital lease obligations0     
Operating lease, liability12
Liabilities, other than long-term debt2112226677
Deferred revenue and credits 006277
Deferred revenue19
Other liabilities111    
Derivative instruments and hedges, liabilities 01224 
Other undisclosed noncurrent liabilities 3    23
Total noncurrent liabilities:35732266101
Total liabilities:71391341392128
Stockholders' equity
Stockholders' equity attributable to parent, including:103101772041(24)(23)
Common stock0000000
Additional paid in capital267196142373370349328
Accumulated other comprehensive income (loss)0  (0)(0)(0)0
Accumulated deficit(164)(95)(64)(354)(329)(373)(352)
Warrants and rights outstanding      23
Other undisclosed stockholders' equity attributable to parent      (23)
Total stockholders' equity:103101772041(24)(23)
TOTAL LIABILITIES AND EQUITY:17414090245468104

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenue, net1 771512
Gross profit:22133 771512
Operating expenses(93)(44)(21)(24)(50)(46)(39)
Operating income (loss):(70)(31)(18)(24)27(31)(26)
Nonoperating income (expense)0  0179(2)
Investment income, nonoperating0    9(2)
Other nonoperating income   017  
Interest and debt expense(0)(0)(5)    
Other undisclosed income from continuing operations before equity method investments, income taxes   0000
Income (loss) from continuing operations before income taxes:(70)(31)(23)(24)44(22)(28)
Income tax expense (benefit)     0(0)
Net income (loss):(70)(31)(23)(24)44(22)(28)
Other undisclosed net income attributable to parent110    
Net income (loss) attributable to parent:(69)(30)(23)(24)44(22)(28)
Preferred stock dividends and other adjustments  (1)    
Net income (loss) available to common stockholders, basic:(69)(30)(24)(24)44(22)(28)
Dilutive securities, effect on basic earnings per share    (4)(9) 
Net income (loss) available to common stockholders, diluted:(69)(30)(24)(24)40(31)(28)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(70)(31)(23)(24)44(22)(28)
Other comprehensive income0      
Comprehensive income (loss):(70)(31)(23)(24)44(22)(28)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent11(1)0(0)(0)0
Comprehensive income (loss), net of tax, attributable to parent:(69)(30)(24)(24)44(22)(28)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: